Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Swiss Exchange  >  Novartis AG    NOVN   CH0012005267

NOVARTIS AG

(NOVN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Novartis AG
Novartis is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales break down by family of products as follows:

- pharmaceutical products (79.5%): used to treat cardiovascular, respiratory, and dermatological diseases, gastrointestinal disorders, cancers, central nervous system disorders, hormone imbalances, etc.;

- generic drugs (20.5%; Sandoz).

Net sales break down geographically as follows: Switzerland (1.7%), Germany (8.7%), France (5.1%), Europe (22.3%), the United States (34.3%), Americas (7.2%) and Asia/Africa/Australasia (20.7%).

On 9 April 2019, the group finalised the spin-off of Alcon.

Number of employees : 103 914 people.
Sales per Business
2019
CHF (in Million)%
Innovative Medicines37,48079.4%
Sandoz9,67120.5%
Sales per region
2019
CHF (in Million)%
United States16,17934.3%
Europe10,45822.2%
Asia/Africa/Australasia7,09915%
Germany4,0948.7%
Canada & Latin America3,4127.2%
Japan2,6395.6%
France2,4275.1%
Switzerland842.731.8%
Managers
NameAgeSinceTitle
Vasant Narasimhan432018Chief Executive Officer
Jörg Reinhardt631982Independent Non-Executive Chairman
Harry Werner Kirsch542013Chief Financial Officer
John Tsai, Dr.522018Chief Medical Officer
Elizabeth Theophille522016Chief Technology & Digital Officer
Srikant T. Madhav Datar, Dr.65-Independent Non-Executive Director
Andreas von Planta, Dr.65-Independent Non-Executive Director
Ann Marie Fudge682008Independent Non-Executive Director
Enrico Cipro Vanni, Dr.682013Vice Chairman
Charles L. Sawyers, Dr.602013Independent Non-Executive Director
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 2,467,060,920 2,144,934,548 86.9% 192,554,684 7.8% 86.9%
Shareholders
NameEquities%
Sandoz Family Foundation 89,193,765 3.62%
Novartis AG 75,183,131 3.05%
The Vanguard Group, Inc. 68,340,108 2.77%
Norges Bank Investment Management 54,262,768 2.20%
Novartis Foundation For Employee Participation 53,983,628 2.19%
UBS Asset Management Switzerland AG 52,845,411 2.14%
Wellington Management Co. LLP 45,134,603 1.83%
Capital Research & Management Co. (Global Investors) 37,852,195 1.53%
Credit Suisse Asset Management (Schweiz) AG 32,192,056 1.30%
Capital Research & Management Co. (World Investors) 27,340,811 1.11%
Holdings
NameEquities%Valuation
Novartis India Limited (500672) 17,450,68070.7%147,444,460 USD
Molecular Partners AG (MOLN) 1,739,1305.97%38,139,225 USD
Gamida Cell Ltd. (GMDA) 4,336,7598.77%22,030,736 USD
Pliant Therapeutics, Inc. (PLRX) 803,5262.27%17,372,232 USD
XOMA Corporation (XOMA) 539,1314.89%13,375,840 USD
Mereo BioPharma Group plc (MPH) 15,703,8714.64%7,309,838 USD
Ayala Pharmaceuticals Inc 632,1114.95%7,199,744 USD
Oxurion NV (OXUR) 2,177,2265.69%6,213,542 USD
GenSight Biologics S.A. (SIGHT) 1,390,4873.50%5,628,483 USD
Aerpio Pharmaceuticals, Inc. (ARPO) 635,2361.51%851,216 USD
Markets and indexes
-
- Domestic Standard
- SMI / FTSE Eurotop 100, Low Carbon 100 Europe, Stoxx Europe 50, STOXX Europe 600, Stoxx Global 200
Stock Exchange Codes
- Bloomberg Code :  
- Reuters Code :  NOVN.S
- Datastream Code :  S:NOVS
Company contact information
Novartis AG
Lichtstrasse 35
CH-4056 Basel, Basel-Stadt


Phone : +41 61 324 11 11
Fax : +41 61 324 80 01
web site : http://www.novartis.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of Novartis AG
Sector Pharmaceuticals - NEC
1st jan.Capitalization (M$)
NOVARTIS AG-5.49%205 415
JOHNSON & JOHNSON1.08%388 168
ROCHE HOLDING AG-4.59%284 650
PFIZER, INC.6.17%219 056
MERCK & CO., INC.-10.34%206 324
ABBVIE INC.17.51%183 680
NOVO NORDISK A/S7.85%156 152
BRISTOL-MYERS SQUIBB COMPANY-2.77%141 031
ASTRAZENECA PLC2.54%137 451
ELI LILLY AND COMPANY10.75%131 962
AMGEN INC.-6.63%131 035
SANOFI-6.16%127 364
GLAXOSMITHKLINE PLC-22.37%92 309
CHUGAI PHARMACEUTICAL CO., LTD.47.20%78 894
JIANGSU HENGRUI MEDICINE CO., LTD.20.01%70 444
DAIICHI SANKYO COMPANY, LIMITED51.62%68 197
BAYER AG-33.15%57 642
TAKEDA PHARMACEUTICAL COMPANY LIMITED-11.38%55 889
HANSOH PHARMACEUTICAL GROUP COMPANY LIMITED38.61%27 907
ASTELLAS PHARMA INC.-19.68%26 723
CHANGCHUN HIGH & NEW TECHNOLOGY INDUSTRY (GROUP) INC.69.04%23 502